Inovio Pharmaceuticals Inc (INO)

6.01
NASDAQ : Health Care
Prev Close 6.01
Day Low/High 5.98 / 6.13
52 Wk Low/High 5.83 / 11.00
Avg Volume 1.87M
Exchange NASDAQ
Shares Outstanding 77.56M
Market Cap 466.16M
EPS -1.00
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Adding to a Name on Weakness

It's hard to ignore INO's price this far below our cost basis.

Biotech Movers: Vertex Continues to Move on Data for CF Regimen

Biotech Movers: Vertex Continues to Move on Data for CF Regimen

Vertex Pharmaceuticals, FibroGen and Inovio Pharmaceuticals were among the biotech stock movers in premarket trading trading on July 19.

A Pharma Pairs Trade

We'll take some profits in AcelRx and lower our cost basis on Inovio.

Stocks Under $10 Weekly Summary

We brought a new name into the portfolio last week as the Fed's comments helped lift the market.

Adding to a Biotech Position

We'll lower our cost basis on Inovio Pharmaceuticals.

Stocks Under $10 Weekly Summary

We made no trades during the holiday-shortened week, but added to our natural hedge today.

Biotech Movers: Exelixis, Omeros, Inovio

Biotech Movers: Exelixis, Omeros, Inovio

Exelixis, Omeros and Inovio Pharmaceuticals were among the biotech movers in premarket trading on July 10.

Inovio's DNA-based Monoclonal Antibody Platform Achieves Further Proof-of-Principle Validation

Inovio's DNA-based Monoclonal Antibody Platform Achieves Further Proof-of-Principle Validation

Inovio dMAb® product induces complete protection against lethal challenge with influenza A & B viruses in published preclinical study

Stocks Under $10 Weekly Summary

We added a name to the portfolio's Bullpen as a whirlwind quarter came to an end.

Inovio Announces Leadership Appointments

Stocks Under $10 Weekly Summary

We exited 2 positions and took some profits during a busy week for the portfolio.

Stocks Under $10 Weekly Summary

We initiated a new position and made several other trades during a week of twists and turns.

Stocks Under $10 Weekly Summary

We initiated 2 new positions in a week dominated by political events.

Adding to Inovio Pharmaceuticals

INO has reached our bid levels.

Initiating Position in Biotech; Update on ACRX

We're buying a small position in Inovio Pharmaceuticals and downgrading AcelRx.

Inovio Pharmaceuticals: Cramer's Top Takeaways

Inovio Pharmaceuticals: Cramer's Top Takeaways

Jim Cramer takes a closer look at Inovio Pharmaceuticals, a small biotech developing DNA-based immunotherapies to treat cancer.

Stay Focused, People!: Cramer's 'Mad Money' Recap (Thursday, 6/8/17)

Stay Focused, People!: Cramer's 'Mad Money' Recap (Thursday, 6/8/17)

Jim Cramer says the story is less about Comey vs. Trump than it is about Nvidia vs. Nordstrom.

Biotech Movers: NewLink, Inovio, Juno

Biotech Movers: NewLink, Inovio, Juno

NewLink Genetics, Inovio Pharmaceuticals and Juno Therapeutics were among the biotech stock movers in premarket trading on Thursday.

Inovio Begins Phase 3 Clinical Trial Of VGX-3100 For The Treatment Of HPV-Related Cervical Pre-Cancer 

FDA removes clinical hold on phase 3; Inovio to immediately begin recruiting subjects

Inovio Zika Vaccine Prevents Persistence Of Virus And Damage In Male Reproductive Tract In Pre-Clinical Study

Zika DNA vaccine may protect against sexual transmission

These Stocks Have Changed Direction

These Stocks Have Changed Direction

Finding bullish and bearish reversals in the market.

Inovio Announces Clinical Trial Collaboration To Evaluate A Novel T-cell Immunotherapy In Combination With A PD-L1 Checkpoint Inhibitor

Phase 1b/2 clinical trial to evaluate combination of Inovio's T cell immunotherapy INO-5401 and Genentech's PD-L1 checkpoint inhibitor atezolizumab

Biotech Movers: Inovio, Neurocrine, Alnylam

Biotech Movers: Inovio, Neurocrine, Alnylam

Inovio Pharmaceuticals, Neurocrine Biosciences and Alnylam Pharmaceuticals were among the biotech movers in premarket trading on Wednesday.

Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates In A Clinical Study

Amongst highest levels of immune responses ever demonstrated in an HIV vaccine human study